0001593968-22-001522.txt : 20221013
0001593968-22-001522.hdr.sgml : 20221013
20221013060259
ACCESSION NUMBER: 0001593968-22-001522
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221010
FILED AS OF DATE: 20221013
DATE AS OF CHANGE: 20221013
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vanhove Geertrui
CENTRAL INDEX KEY: 0001771994
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39635
FILM NUMBER: 221308018
MAIL ADDRESS:
STREET 1: 1333 S. SPECTRUM BLVD #100
CITY: CHANDLER
STATE: AZ
ZIP: 85286
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Surrozen, Inc./DE
CENTRAL INDEX KEY: 0001824893
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 981556622
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 171 OYSTER POINT BLVD
STREET 2: SUITE 400
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-475-2820
MAIL ADDRESS:
STREET 1: 171 OYSTER POINT BLVD
STREET 2: SUITE 400
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: Consonance-HFW Acquisition Corp.
DATE OF NAME CHANGE: 20200915
4
1
primary_01.xml
PRIMARY DOCUMENT
X0306
4
2022-10-10
0001824893
Surrozen, Inc./DE
SRZN
0001771994
Vanhove Geertrui
C/O SURROZEN, INC.
171 OYSTER POINT BLVD., SUITE 400
SOUTH SAN FRANCISCO
CA
94080
false
true
false
false
Chief Medical Officer
Option (right to buy)
10.77
2022-10-10
4
D
false
24587
D
2021-02-01
2031-02-22
Common Stock
24587
0
D
Option (right to buy)
10.25
2022-10-10
4
D
false
10427
D
2022-08-12
2031-08-12
Common Stock
10427
0
D
Option (right to buy)
10.25
2022-10-10
4
D
false
26220
D
2022-08-12
2031-08-12
Common Stock
26220
0
D
Option (right to buy)
10.77
2022-10-10
4
D
false
1760
D
2021-02-01
2031-02-22
Common Stock
1760
0
D
Option (right to buy)
2.16
2022-10-10
4
A
false
26220
A
2022-08-12
2031-08-12
Common Stock
26220
26220
D
Option (right to buy)
2.16
2022-10-10
4
A
false
10427
A
2022-08-12
2031-08-12
Common Stock
10427
10427
D
Option (right to buy)
2.16
2022-10-10
4
A
false
24587
A
2021-02-01
2031-02-22
Common Stock
24587
24587
D
Option (right to buy)
2.16
2022-10-10
4
A
false
1760
A
2021-02-01
2031-02-22
Common Stock
1760
1760
D
The reporting person agreed to cancellation of an option granted to her on 2/23/2021, in exchange for a new option having a lower exercise price.
The shares subject to the options vest and become exercisable in a series of 48 equal monthly installments beginning on 2/1/2021, subject to the reporting person's continued employment through the applicable vesting date.
The reporting person agreed to cancellation of an option granted to her on 8/12/2021, in exchange for a new option having a lower exercise price.
Twenty-five percent of the shares subject to the Stock Option vests on 8/12/2022, and the remainder vests in 36 equal monthly installments thereafter for the following three years.
/s/Sheela Mohan-Peterson, Attorney-in-Fact for Geertrui Vanhove
2022-10-12